Microbiome Therapeutic Beats Placebo for Recurrent C. difficile
Investigational oral live microbiome therapeutic superior to placebo in patients with three or more episodes of C. difficile infection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.